Sami Mohammed is an accomplished researcher in the field of regenerative medicine and diabetes therapies, currently serving as a Postdoctoral Researcher at the MERLN Institute for Technology-Inspired Regenerative Medicine since March 2018. With experience as a Postdoctoral Fellow at Université libre de Bruxelles and a NWO Rubicon Research Fellow at Joslin Diabetes Center, Sami has focused on projects related to beta-cell replacement and cell transplantation techniques. A PhD candidate at Radboudumc, Sami's doctoral research involved renal electrolyte handling, employing advanced methodologies such as microfluidic systems and CRISPR-Cas9 gene editing. Earlier career stages included research internships in nuclear medicine and pharmacology, as well as a Graduate Assistant role at Asmara College of Health Sciences. Sami holds an MSc in Biomedical Sciences from Radboud University and a BSc in Pharmacy from the University of Asmara.
This person is not in any teams
MERLN Institute for Technology-Inspired Regenerative Medicine
The MERLN Institute for Technology-Inspired Regenerative Medicine strives to maintain a leading position in the field of biomedical engineering by combining creative research with training a generation of interdisciplinary scientists. MERLN’s activities operate at the interface of biology, engineering and medicine to maximise impact at the level of public involvement and the commercialisation of research. MERLN’s vision is based on sharing knowledge, infrastructure, and ambition!